溴隐亭（CB - 154）对溢乳综合征的临床及激素反应 - Suppr

Suppr

超能文献

Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.

作者信息

Del Pozo E, Varga L, Wyss H, Tolis G, Friesen H, Wenner R, Vetter L, Uettwiler A

出版信息

J Clin Endocrinol Metab. 1974 Jul;39(1):18-26. doi: 10.1210/jcem-39-1-18.

DOI:10.1210/jcem-39-1-18

PMID:4209685

Abstract

摘要

相似文献

Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes.

J Clin Endocrinol Metab. 1974 Jul;39(1):18-26. doi: 10.1210/jcem-39-1-18.

The effect of lergotrile on galactorrhea and gonadotropin secretion.

J Clin Endocrinol Metab. 1975 May;40(5):830-3. doi: 10.1210/jcem-40-5-830.

Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.

Obstet Gynecol. 1975 Jul;46(1):1-11. doi: 10.1097/00006250-197507000-00001.

Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.

Am J Obstet Gynecol. 1975 Feb 1;121(3):375-9. doi: 10.1016/0002-9378(75)90015-0.

Levodopa in Forbes-Albright syndrome.

Can Med Assoc J. 1973 Mar 3;108(5):554.

Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.

Arch Gynakol. 1975;218(2):85-94. doi: 10.1007/BF01395909.

[Advances in the treatment of the galactorrhoea-amenorrhoea-syndrome: Induction of ovulation and inhibition of lactation with 2-Br-alpha-ergo-cryptine (author's transl)].

Geburtshilfe Frauenheilkd. 1974 Jan;34(1):59-64.

Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.

Fertil Steril. 1977 May;28(5):521-5. doi: 10.1016/s0015-0282(16)42550-1.

Galactorrhea in sarcoidosis: dynamic studies of prolactin, growth and gonadotropic hormone levels.

Am J Med Sci. 1979 May-Jun;277(3):289-94.

Ergot treatment of nonpuerperal galactorrhea.

N Engl J Med. 1972 Oct 5;287(14):723. doi: 10.1056/NEJM197210052871417.

引用本文的文献

Matrix augmentation as an efficient method for resolving interaction of bromocriptine with human serum albumin: trouble shooting and simultaneous resolution.

Heliyon. 2019 Jul 27;5(7):e02153. doi: 10.1016/j.heliyon.2019.e02153. eCollection 2019 Jul.

Anovulation and ovulation induction.

Hippokratia. 2006 Jul;10(3):120-7.

The management of prolactin-secreting pituitary tumors.

J Endocrinol Invest. 1981 Oct-Dec;4(4):459-67. doi: 10.1007/BF03348312.

Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.

J Endocrinol Invest. 1982 Nov-Dec;5(6):409-15. doi: 10.1007/BF03350542.

Pituitary tumors--current concepts of diagnosis and therapy.

West J Med. 1980 Sep;133(3):189-96.

The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.

Eur J Clin Pharmacol. 1981;21(2):103-8. doi: 10.1007/BF00637509.

Prolactin-secreting pituitary adenomas.

West J Med. 1983 Nov;139(5):663-72.

Cushing's disease: clinical and laboratory response to bromocriptine therapy.

J Endocrinol Invest. 1984 Dec;7(6):585-8. doi: 10.1007/BF03349490.

Successful treatment of mastodynia with the prolactin inhibitor bromocryptine (CB 154).

Arch Gynakol. 1975 Dec 16;220(1):83-7. doi: 10.1007/BF00673151.

Editorial: Bromocriptine--a changing scene.

Br Med J. 1975 Dec 20;4(5998):667-8. doi: 10.1136/bmj.4.5998.667.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验